|
87
|
274
|
4dflA |
Crystal structure of spleen tyrosine kinase complexed with a sulfonamidopyrazine piperidine inhibitor |
|
105
|
362
|
4crlA |
Crystal structure of human cdk8-cyclin c in complex with cortistatin a |
|
92
|
307
|
4d9uA |
Rsk2 c-terminal kinase domain, (e)-tert-butyl 3-(4-amino-7-(3-hydroxypropyl)-5-p-tolyl-7h-pyrrolo[2,3-d]pyrimidin-6-yl)-2-cyanoacrylate |
|
77
|
262
|
4c3rA |
Structure of dephosphorylated aurora a (122-403) bound to amppcp |
|
101
|
544
|
4cffA |
Structure of full length human ampk in complex with a small molecule activator, a thienopyridone derivative (a-769662) |
|
86
|
300
|
4cfwA |
Structure-based design of c8-substituted o6-cyclohexylmethoxyguanine cdk1 and 2 inhibitors. |
|
145
|
454
|
4btfA |
Structure of mlkl |
|
81
|
279
|
4c4eA |
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase mps1 |
|
47
|
171
|
4bvuA |
Structure of shigella effector ospg in complex with host ubch5c- ubiquitin conjugate |
|
77
|
279
|
4c4hA |
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase mps1 |
|
77
|
280
|
4c4gA |
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase mps1 |
|
95
|
308
|
4cmtA |
Structure of the human anaplastic lymphoma kinase in complex with the inhibitor 3-((1r)-1-(5-fluoro-2-(2h-1,2,3-triazol-2-yl)phenyl)ethoxy)- 5-(3-(methylsulfonyl)phenyl)pyridin-2-amine |
|
107
|
322
|
4c02A |
Crystal structure of human acvr1 (alk2) in complex with fkbp12.6 and dorsomorphin |
|
87
|
297
|
4cfmA |
Structure-based design of c8-substituted o6-cyclohexylmethoxyguanine cdk1 and 2 inhibitors. |
|
87
|
309
|
4c8bA |
Structure of the kinase domain of human ripk2 in complex with ponatinib |
|
95
|
292
|
4btjA |
Ttbk1 in complex with atp |
|
98
|
308
|
4cd0A |
Structure of l1196m mutant human anaplastic lymphoma kinase in complex with 2-(5-(6-amino-5-((r)-1-(5-fluoro-2-(2h-1,2,3-triazol-2- yl)phenyl)ethoxy)pyridin-3-yl)-4-methylthiazol-2-yl)propane-1,2-diol |
|
93
|
292
|
4btmA |
Ttbk1 in complex with inhibitor |
|
105
|
338
|
4c36A |
Pka-s6k1 chimera with compound 15e (cct147581) bound |
|
77
|
264
|
4c3pA |
Structure of dephosphorylated aurora a (122-403) bound to tpx2 and amppcp |
|
69
|
291
|
4c0tA |
Candida albicans pkh kinase domain |
|
88
|
301
|
4cfvA |
Structure-based design of c8-substituted o6-cyclohexylmethoxyguanine cdk1 and 2 inhibitors. |
|
106
|
340
|
4c34A |
Pka-s6k1 chimera with staurosporine bound |
|
94
|
308
|
4cnhA |
Structure of the human anaplastic lymphoma kinase in complex with the inhibitor 3-((1r)-1-(5-fluoro-2-methoxyphenyl)ethoxy)-5-(1-methyl-1h- 1,2,3-triazol-5-yl)pyridin-2-amine |
|
108
|
412
|
4bwkA |
Structure of neurospora crassa pan3 pseudokinase |
|
80
|
299
|
4cfxA |
Structure-based design of c8-substituted o6-cyclohexylmethoxyguanine cdk1 and 2 inhibitors. |
|
81
|
271
|
4c7tA |
Focal adhesion kinase catalytic domain in complex with a diarylamino- 1,3,5-triazine inhibitor |
|
72
|
263
|
4byiA |
Aurora a kinase bound to a highly selective imidazopyridine inhibitor |
|
93
|
290
|
4btkA |
Ttbk1 in complex with inhibitor |
|
96
|
308
|
4cmuA |
Structure of the human anaplastic lymphoma kinase in complex with the inhibitor (10r)-7-amino-12-fluoro-1,3,10,16-tetramethyl-16,17-dihydro- 1h-8,4-(metheno)pyrazolo(4,3-h)(2,5,11)benzoxadiazacyclotetradecin-15(10h)-one |
|
108
|
338
|
4c33A |
Pka-s6k1 chimera apo |
|
124
|
413
|
4bwxA |
Structure of neurospora crassa pan3 pseudokinase mutant |
|
87
|
265
|
4cegA |
Crystal structure of aurora a 122-403 c290a, c393a bound to adp |
|
89
|
287
|
4c62A |
Inhibitors of jak2 kinase domain |
|
112
|
338
|
4c37A |
Pka-s6k1 chimera with compound 21a (cct196539) bound |
|
96
|
309
|
4ccuA |
Structure of the human anaplastic lymphoma kinase in complex with 2-(5-(6-amino-5-((r)-1-(5-fluoro-2-(2h-1,2,3-triazol-2-yl)phenyl)ethoxy) pyridin-3-yl)-4-methylthiazol-2-yl)propan-2-ol |
|
83
|
273
|
4bznA |
Crystal structure of pim1 in complex with a pyrrolo(1,2-a)pyrazinone inhibitor |
|
88
|
280
|
4c4fA |
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase mps1 |
|
107
|
340
|
4c35A |
Pka-s6k1 chimera with compound 1 (nu1085) bound |
|
89
|
269
|
4c2wA |
Crystal structure of aurora b in complex with amp-pnp |
|
96
|
309
|
4cmoA |
Structure of the human anaplastic lymphoma kinase in complex with the inhibitor 2-((1r)-1-((3-amino-6-(2-methoxypyridin-3-yl)pyrazin-2-yl) oxy)ethyl)-4-fluoro-n-methylbenzamide |
|
83
|
261
|
4c3fA |
Structure of lck in complex with a compound discovered by virtual fragment linking |
|
98
|
308
|
4cliA |
Structure of the human anaplastic lymphoma kinase in complex with pf- 06463922 ((10r)-7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16, 17-tetrahydro-2h-8,4-(metheno)pyrazolo(4,3-h)(2,5,11) benzoxadiazacyclotetradecine-3-carbonitrile). |
|
82
|
298
|
4bzdA |
Structure of cdk2 in complex with a benzimidazopyrimidine |
|
87
|
302
|
4cfuA |
Structure-based design of c8-substituted o6-cyclohexylmethoxyguanine cdk1 and 2 inhibitors. |
|
71
|
263
|
4byjA |
Aurora a kinase bound to a highly selective imidazopyridine inhibitor |
|
89
|
287
|
4c61A |
Inhibitors of jak2 kinase domain |
|
108
|
337
|
4c38A |
Pka-s6k1 chimera with compound 21e (cct239066) bound |
|
93
|
308
|
4ccbA |
Structure of the human anaplastic lymphoma kinase in complex with 3-((r)-1-(5-fluoro-2-(2h-1,2,3-triazol-2-yl)phenyl)ethoxy)-5-(5-methyl-1h- pyrazol-4-yl)pyridin-2-amine |
|
82
|
273
|
4bzoA |
Crystal structure of pim1 in complex with a pyrrolo-pyrazinone inhibitor |
